Ana
Alfonso Piérola
Investigadora Consultora
David Geffen School of Medicine at UCLA
Los Ángeles, Estados UnidosPublications en collaboration avec des chercheurs de David Geffen School of Medicine at UCLA (2)
2022
-
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy (Nature Medicine, (2022), 28, 3, (557-567), 10.1038/s41591-022-01696-4)
Nature Medicine
-
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
Nature Medicine, Vol. 28, Núm. 3, pp. 557-567